Orbimed Advisors, 10% Owner: Passage BIO PASG Sell · Filed 24/09/18

Trade details

Type: Insider sale
Amount: $81,322
Shares · price: 111,400 sh · $0.73 a share
Held after: 7,859,500 sh
Stock: Passage BIO PASG
Person: Orbimed Advisors10% Owner
Trade date: 24/09/17
Filed: 24/09/18
Days to filing: 1 days

Sold 1.4% of holdings

Share of holding sold: 1.4%

Passage BIO trades, last 26 weeks

What else happened in Passage BIO around then

Filed or reported within 30 days of the trade day · 24/08/18~24/10/17

Orbimed Advisors's recent trades

Orbimed AdvisorsDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$10M
588,235 sh
$10M
Filed 09/30
Traded 09/28
Orbimed AdvisorsDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$5.1M
300,249 sh
$5.1M
Filed 09/30
Traded 09/28
Orbimed AdvisorsDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$1M
61,516 sh
$1M
Filed 09/30
Traded 09/28
Orbimed AdvisorsDirector
BuyElectra Therapeutics
Buy
Electra Therapeutics
ETRA
$15M
1,000,000 sh
$15M
Filed 09/23
Traded 09/21
Orbimed AdvisorsDirector
BuyElectra Therapeutics
Buy
Electra Therapeutics
ETRA
$5M
333,333 sh
$5M
Filed 09/23
Traded 09/21